Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Cancer Aggressiveness”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Not applicableStudy completedNCT01672411
What this trial is testing

Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate Cancer

Who this might be right for
Prostate Cancer
University Of Perugia 250
Not applicableStudy completedNCT02451345
What this trial is testing

Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle Model

Who this might be right for
Prostate Cancer
University of California, San Francisco 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT04592237
What this trial is testing

Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer

Who this might be right for
Aggressive Variant Prostate CarcinomaCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
M.D. Anderson Cancer Center 120
Not applicableUnknownNCT03413007
What this trial is testing

Correlation Between iXip and Final Pathology Specimen From Radical Prostatectomy: a Multicenter Prospective Trial

Who this might be right for
Prostate Cancer
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 300
Large-scale testing (Phase 3)Not Yet RecruitingNCT05232578
What this trial is testing

Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher Aggressiveness

Who this might be right for
Prostate Cancer
General University Hospital, Prague 380
Not applicableStudy completedNCT02485379
What this trial is testing

Assessment of Prostate MRI Before Prostate Biopsies

Who this might be right for
Prostate Cancer
Hospices Civils de Lyon 275
Testing effectiveness (Phase 2)UnknownNCT03307460
What this trial is testing

UPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness

Who this might be right for
Prostate Cancer
Rigshospitalet, Denmark 52
Testing effectiveness (Phase 2)Looking for participantsNCT07179783
What this trial is testing

Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate Cancer Metastatic Castration-ResistantProstate Adenocarcinoma With Neuroendocrine Differentiation
Tianjin Medical University Second Hospital 28
Testing effectiveness (Phase 2)Looking for participantsNCT06738303
What this trial is testing

Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CancerMetastatic Castration-resistant Prostate Cancer
Case Comprehensive Cancer Center 44
Not applicableStudy completedNCT06773858
What this trial is testing

Genetic Studies of Prostate Cancer Aggressiveness and Prognosis

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate Cancer After a Radical Treatment
Karolinska Institutet 2,291
Not applicableActive Not RecruitingNCT02095249
What this trial is testing

Prostate Hypoxia - TIC

Who this might be right for
Prostate Cancer
University Health Network, Toronto 39
Not applicableNot Yet RecruitingNCT06662708
What this trial is testing

Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer

Who this might be right for
Prostate CancerProstate Intraductal CarcinomaProstate Cancer Aggressiveness+2 more
Shao Pengfei 200
Testing effectiveness (Phase 2)Study completedNCT05005728
What this trial is testing

XmAb®20717 (Vudalimab) Alone or in Combination With Chemotherapy or Targeted Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer
Xencor, Inc. 72
Not applicableStudy completedNCT02689271
What this trial is testing

CombIning advaNces in imagiNg With biOmarkers for improVed Diagnosis of Aggressive prosTate cancEr

Who this might be right for
Prostate Cancer
University College, London 365
Not applicableActive Not RecruitingNCT01514669
What this trial is testing

Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer

Who this might be right for
Prostate Cancer
University of Arkansas 75
Not applicableActive Not RecruitingNCT01464216
What this trial is testing

MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness

Who this might be right for
Prostatic NeoplasmsGenital Neoplasms, MaleProstatic Diseases
Oslo University Hospital 120
Not applicableStudy completedNCT01347476
What this trial is testing

Aggressive Prostate Cancers in Elderly Patients

Who this might be right for
Prostatic Neoplasms
Seoul National University Hospital 1,333
Not applicableStudy completedNCT01780701
What this trial is testing

Magnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 66
Not applicableStudy completedNCT05384002
What this trial is testing

An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum

Who this might be right for
Prostate CancerProstate Cancer MetastaticProstate Cancer Recurrent+1 more
Fondazione del Piemonte per l'Oncologia 14,000
Not applicableStudy completedNCT03397160
What this trial is testing

Pioneering Advances in Care and Education (PACE)

Who this might be right for
Decision Support Systems, ClinicalProstate Cancer
University of California, San Francisco 119
Load More Results